SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CTIX - Cellceutix Corporation
An SI Board Since May 2008
Posts SubjectMarks Bans Symbol
106 17 0 CTIX
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
81Cellceutix Phase 2 Trial of New Oral Treatment for Psoriasis Nearing CompleSavant-1/25/2016
80Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of KSavant-1/22/2016
79Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the TreatmSavant-1/21/2016
78Cellceutix Submits Briefing Book for Phase 2 Trial of p53 Targeting Drug foSavant-1/21/2016
77Presentation recording reminder.... Cellceutix will be presenting on MoSavant-1/15/2016
76Brilacidin Lyophilized as Cellceutix Prepares to Bring First New Class of ASavant-1/15/2016
75Cellceutix Receives Rare Pediatric Disease Designation From FDA for KevetriSavant-12/1/2015
74Cellceutix Retains Former Durata Executive Ronald Trust as Regulatory AffaiSavant-11/30/2015
73FDA Grants Fast Track Designation to Cellceutix's Brilacidin-OM for OraSavant-11/30/2015
72Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the TreatmSavant-11/30/2015
71Cellceutix Selects Docetaxel for Combination Arm in Planned Phase 2 Trial fSavant-11/30/2015
70Cellceutix Completes Cohort in Kevetrin Clinical Trial; Cheers to Ocata TheSavant-11/30/2015
69Cellceutix to Start Brilacidin Phase 3 Program in ABSSSI Company Reports SucceSavant-7/20/2015
68Cellceutix's Kevetrin Receives FDA Orphan Drug Designation for the TreatmentSavant-7/20/2015
67Phase II centers added Briacidin for Oral Mucositis Phase I Kevetrin trial apprSavant-6/16/2015
66Cellceutix Plans Clinical Trial in Patients With Ulcerative Proctitis *& ProSavant-1/26/2015
65Jan 12 presentation online.... Cellceutix Invites All to Attend Company&Savant-1/22/2015
64Cellceutix Reports Spleen Lesion 'Disappears' in Patient With MetSavant-1/22/2015
63Cellceutix Phase 2b Clinical Trial of Brilacidin Accepted for Oral PresenSavant-1/22/2015
62[X] #CellceutixCorporation$CTIX up 13.5% news: Potential Major Breakthrough in SI Ron (Crazy Music Man)-1/20/2015
61Would any one like to volunteer being the moderator of this board?SI Ron (Crazy Music Man)-1/20/2015
60I'm watching several in their pipeline. Brilacidin is perhaps of most interSavant-1/11/2015
59Well, they are a little behind in getting the combo AML trial going. 4th quartetuck-1/11/2015
58From the CEO’s Desk--Overview, Sept/Oct 2014 CELLCEUTIX PROVIDES UPDATE TO SHARESavant-1/11/2015
57 Cellceutix Releases Confidence Interval Statistics Showing Clinical SucceSavant-1/5/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News